カテゴリー： QYResearch, 世界

世界の低酸素誘導因子1アルファ阻害剤市場 2019年

【英語タイトル】Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Professional Survey Report 2019

・商品コード：DATA909X09523
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：114
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

※本調査レポートは、低酸素誘導因子1アルファ阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BC-001、CASI-2ME2、CRLX-101、その他に、用途別には、固形腫瘍、急性骨髄性白血病、大腸癌、その他にセグメント区分し、低酸素誘導因子1アルファ阻害剤の世界市場を分析しました。

・エグゼクティブ・サマリー
・低酸素誘導因子1アルファ阻害剤の世界市場概要
・低酸素誘導因子1アルファ阻害剤の製造コスト構成分析
・低酸素誘導因子1アルファ阻害剤の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・低酸素誘導因子1アルファ阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・低酸素誘導因子1アルファ阻害剤のセグメント分析（種類別）
（BC-001、CASI-2ME2、CRLX-101、その他）
・低酸素誘導因子1アルファ阻害剤のセグメント分析（用途別）
（固形腫瘍、急性骨髄性白血病、大腸癌、その他）
・低酸素誘導因子1アルファ阻害剤の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Aileron Therapeutics, Inc.、CASI Pharmaceuticals Inc.、Cerulean Pharma, Inc.、F. Hoffmann-La Roche Ltd.、InterMed Discovery GmbH、OncoImmune, Inc.、Peloton Therapeutics, Inc.、RXi Pharmaceuticals Corporation、Sorrento Therapeutics, Inc.、Transcriptogen Ltd、Vascular Biogenics Ltd.、）
・低酸素誘導因子1アルファ阻害剤の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Hypoxia Inducible Factor 1 Alpha Inhibitor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Hypoxia Inducible Factor 1 Alpha Inhibitor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypoxia Inducible Factor 1 Alpha Inhibitor market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hypoxia Inducible Factor 1 Alpha Inhibitor in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hypoxia Inducible Factor 1 Alpha Inhibitor manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Aileron Therapeutics, Inc.
CASI Pharmaceuticals Inc.
Cerulean Pharma, Inc.
F. Hoffmann-La Roche Ltd.
InterMed Discovery GmbH
OncoImmune, Inc.
Peloton Therapeutics, Inc.
RXi Pharmaceuticals Corporation
Sorrento Therapeutics, Inc.
Transcriptogen Ltd
Vascular Biogenics Ltd.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
BC-001
CASI-2ME2
CRLX-101
Others

Segment by Application
Solid Tumor
Acute Myelocytic Leukemia
Colorectal Cancer
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Hypoxia Inducible Factor 1 Alpha Inhibitor
1.1 Definition of Hypoxia Inducible Factor 1 Alpha Inhibitor
1.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment by Type
1.2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Comparison by Types (2014-2025)
1.2.2 BC-001
1.2.3 CASI-2ME2
1.2.4 CRLX-101
1.2.5 Others
1.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment by Applications
1.3.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Comparison by Applications (2014-2025)
1.3.2 Solid Tumor
1.3.3 Acute Myelocytic Leukemia
1.3.4 Colorectal Cancer
1.3.5 Others
1.4 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Overall Market
1.4.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2014-2025)
1.4.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production (2014-2025)
1.4.3 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
1.4.4 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
1.4.5 China Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
1.4.6 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
1.4.7 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
1.4.8 India Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor
2.3 Manufacturing Process Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor
2.4 Industry Chain Structure of Hypoxia Inducible Factor 1 Alpha Inhibitor

3 Development and Manufacturing Plants Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor
3.1 Capacity and Commercial Production Date
3.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hypoxia Inducible Factor 1 Alpha Inhibitor
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Production and Capacity Analysis
4.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Analysis
4.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Price Analysis
4.4 Market Concentration Degree

5 Hypoxia Inducible Factor 1 Alpha Inhibitor Regional Market Analysis
5.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Production by Regions
5.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production by Regions
5.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Regions
5.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption by Regions
5.3 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
5.3.1 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Production
5.3.2 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
5.4 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
5.4.1 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Production
5.4.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
5.5 China Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
5.5.1 China Hypoxia Inducible Factor 1 Alpha Inhibitor Production
5.5.2 China Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
5.6 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
5.6.1 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Production
5.6.2 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
5.7 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
5.7.1 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Production
5.7.2 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
5.8 India Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
5.8.1 India Hypoxia Inducible Factor 1 Alpha Inhibitor Production
5.8.2 India Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export

6 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment Market Analysis (by Type)
6.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production by Type
6.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Type
6.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Type

7 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment Market Analysis (by Application)
7.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption by Application
7.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Market Share by Application (2014-2019)

8 Hypoxia Inducible Factor 1 Alpha Inhibitor Major Manufacturers Analysis
8.1 Aileron Therapeutics, Inc.
8.1.1 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.1.2 Aileron Therapeutics, Inc. Product Introduction, Application and Specification
8.1.3 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 CASI Pharmaceuticals Inc.
8.2.1 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.2.2 CASI Pharmaceuticals Inc. Product Introduction, Application and Specification
8.2.3 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Cerulean Pharma, Inc.
8.3.1 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.3.2 Cerulean Pharma, Inc. Product Introduction, Application and Specification
8.3.3 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.4.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
8.4.3 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 InterMed Discovery GmbH
8.5.1 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.5.2 InterMed Discovery GmbH Product Introduction, Application and Specification
8.5.3 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 OncoImmune, Inc.
8.6.1 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.6.2 OncoImmune, Inc. Product Introduction, Application and Specification
8.6.3 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Peloton Therapeutics, Inc.
8.7.1 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.7.2 Peloton Therapeutics, Inc. Product Introduction, Application and Specification
8.7.3 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 RXi Pharmaceuticals Corporation
8.8.1 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.8.2 RXi Pharmaceuticals Corporation Product Introduction, Application and Specification
8.8.3 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Sorrento Therapeutics, Inc.
8.9.1 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.9.2 Sorrento Therapeutics, Inc. Product Introduction, Application and Specification
8.9.3 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Transcriptogen Ltd
8.10.1 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.10.2 Transcriptogen Ltd Product Introduction, Application and Specification
8.10.3 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Vascular Biogenics Ltd.

9 Development Trend of Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor Market
9.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Trend Analysis
9.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Volume and Value) Forecast 2019-2025
9.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Regional Market Trend
9.2.1 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
9.2.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
9.2.3 China Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
9.2.4 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
9.2.5 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
9.2.6 India Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
9.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Trend (Product Type)
9.4 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Hypoxia Inducible Factor 1 Alpha Inhibitor
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share by Types in 2018
Figure BC-001 Product Picture
Figure CASI-2ME2 Product Picture
Figure CRLX-101 Product Picture
Figure Others Product Picture
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Market Share by Applications in 2018
Figure Solid Tumor
Figure Acute Myelocytic Leukemia
Figure Colorectal Cancer
Figure Others
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (Million USD) (2014-2025)
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs) (2014-2025)
Figure North America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Million USD) (2014-2025)
Figure Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Million USD) (2014-2025)
Figure China Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Million USD) (2014-2025)
Figure Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Million USD) (2014-2025)
Figure Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Million USD) (2014-2025)
Figure India Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Million USD) (2014-2025)
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor in 2018
Figure Manufacturing Process Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor
Figure Industry Chain Structure of Hypoxia Inducible Factor 1 Alpha Inhibitor
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Plants Distribution
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs) of Major Manufacturers (2014-2019)
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share of Major Manufacturers (2014-2019)
Figure Hypoxia Inducible Factor 1 Alpha Inhibitor Production Share by Manufacturers in 2018
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share of Major Manufacturers (2014-2019)
Figure Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Share by Manufacturers in 2018
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production by Regions 2014-2019 (K Pcs)
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share by Regions 2014-2019
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share by Regions in 2018
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Regions 2014-2019 (Million USD)
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Regions 2014-2019
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Regions in 2018
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption by Regions 2014-2019 (K Pcs)
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Market Share by Regions 2014-2019
Figure North America Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table North America Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Consumption Import and Export (K Pcs)
Figure Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Consumption Import and Export (K Pcs)
Figure China Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure China Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table China Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Consumption Import and Export (K Pcs)
Figure Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Consumption Import and Export (K Pcs)
Figure India Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure India Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table India Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Application (2014-2019)
Figure Global Value (Consumption) Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Application (2014-2019)
Table Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Hypoxia Inducible Factor 1 Alpha Inhibitor by Type (2019-2025)
Table Global Consumption (K Pcs) of Hypoxia Inducible Factor 1 Alpha Inhibitor by Application (2019-2025)
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Distributors List
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Aileron Therapeutics, Inc.、CASI Pharmaceuticals Inc.、Cerulean Pharma, Inc.、F. Hoffmann-La Roche Ltd.、InterMed Discovery GmbH、OncoImmune, Inc.、Peloton Therapeutics, Inc.、RXi Pharmaceuticals Corporation、Sorrento Therapeutics, Inc.、Transcriptogen Ltd、Vascular Biogenics Ltd.、

★調査レポート[世界の低酸素誘導因子1アルファ阻害剤市場 2019年] (コード：DATA909X09523)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界の低酸素誘導因子1アルファ阻害剤市場 2019年]についてメールでお問い合わせ

◆関連市場調査レポート◆

腫瘍壊死因子(TNF)阻害薬の世界市場：規模・現状・予測2019-2025
DATA909X19054 / QYResearch / 2019年11月25日 / ※当調査レポートでは、腫瘍壊死因子(TNF)阻害薬の世界市場について調査・分析し、腫瘍壊死因子(TNF)阻害薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ヒュミラ、エンブレル、レミケード、シンポニー/シンポニーアリア、シムジア、バイオシミラー）、用途別（関節リウマチ、乾癬、乾癬性関節炎、クローン病、潰瘍性大腸炎、強直性脊椎炎、若年性特発性関節炎、化膿性汗腺炎、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。・レポートの概要・世界の腫瘍壊死因子(TNF)阻害薬市場動向・主要企業別マーケットシェア・腫瘍壊死因子(TNF)阻害薬の種類別市場規模2014-2019 （ヒュミラ、エンブレル、レミケード、シンポニー/シンポニーアリア、シムジア、バイオシミラー）・腫瘍壊死因子(TNF)阻害薬の用途別市場規模2014-2019 （関節リウマチ、乾癬、乾癬性関節炎、クローン病、潰瘍性大腸炎、強直性脊椎炎、若年性特発性関節炎、化膿性汗腺炎、その他）・腫瘍壊死因子(TNF)阻害薬の北米市場：主要企業・種類別/用途別市場規模・腫瘍壊死因子(TNF)阻害薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response. TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma, so TNF inhibitors may be used in their treatment. The important side effects of TNF inhibitors include lymphomas, infections (especially reactivation of latent tuberculosis), congestive heart failure, demyelinating disease, a lupus-like syndrome, induction of auto-antibodies, injection site reactions, and systemic side effects.The market growth is expected to be driven by new product launches, promising pipeline, increasing incidence of autoimmune diseases, and a significant rise in consumer awareness regarding...

血管内皮増殖因子(VEGF)阻害剤の世界市場：規模・現状・予測2019-2025
DATA909X19071 / QYResearch / 2019年11月25日 / ※当調査レポートでは、血管内皮増殖因子(VEGF)阻害剤の世界市場について調査・分析し、血管内皮増殖因子(VEGF)阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）、用途別（腫瘍学、眼科）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。・レポートの概要・世界の血管内皮増殖因子(VEGF)阻害剤市場動向・主要企業別マーケットシェア・血管内皮増殖因子(VEGF)阻害剤の種類別市場規模2014-2019 （VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）・血管内皮増殖因子(VEGF)阻害剤の用途別市場規模2014-2019 （腫瘍学、眼科）・血管内皮増殖因子(VEGF)阻害剤の北米市場：主要企業・種類別/用途別市場規模・血管内皮増殖因子(VEGF)阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模...Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels. The vascular endothelial growth factor is a protein that can trigger endothelial cells or pre-existing vessels to form new blood vessels. However, overexpression of vascular endothelial growth factor can generate cancerous cells. In 2018, the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Vascular Endothelial Growth Factor (VEGF) Inhibitors status,...

世界の顆粒球マクロファージコロニー刺激因子市場 2019年
DATA909X08574 / QYResearch / 2019年11月15日 / ※本調査レポートは、顆粒球マクロファージコロニー刺激因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CG-0070、ギムシルマブ、GSK-3196165、レンジルマブ、MGN-1601、その他に、用途別には、固形腫瘍、リンパ腫、腎臓癌、肺疾患、その他にセグメント区分し、顆粒球マクロファージコロニー刺激因子の世界市場を分析しました。・エグゼクティブ・サマリー・顆粒球マクロファージコロニー刺激因子の世界市場概要・顆粒球マクロファージコロニー刺激因子の製造コスト構成分析・顆粒球マクロファージコロニー刺激因子の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・顆粒球マクロファージコロニー刺激因子の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・顆粒球マクロファージコロニー刺激因子のセグメント分析（種類別）（CG-0070、ギムシルマブ、GSK-3196165、レンジルマブ、MGN-1601、その他）...The global Granulocyte Macrophage Colony Stimulating Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Granulocyte Macrophage Colony Stimulating Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Granulocyte Macrophage Colony Stimulating Factor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Granulocyte Macrophage Colony Stimulating Factor in North America, Europe, China, Japan, Southeast Asia and...

世界のαグルコシダーゼ市場 2019年
DATA909X10826 / QYResearch / 2019年11月20日 / ※本調査レポートは、αグルコシダーゼの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AT-982、ATB-200、AVRRD-03、JR-162、MOSS-GAA、OXY-2810、その他に、用途別には、グリコーゲン貯蔵病、ポンペ病、その他にセグメント区分し、αグルコシダーゼの世界市場を分析しました。・エグゼクティブ・サマリー・αグルコシダーゼの世界市場概要・αグルコシダーゼの製造コスト構成分析・αグルコシダーゼの開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・αグルコシダーゼの地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・αグルコシダーゼのセグメント分析（種類別）（AT-982、ATB-200、AVRRD-03、JR-162、MOSS-GAA、OXY-2810、その他）...The global Lysosomal Alpha Glucosidase market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Lysosomal Alpha Glucosidase volume and value at global level, regional level and company level. From a global perspective, this report represents overall Lysosomal Alpha Glucosidase market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Lysosomal Alpha Glucosidase in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

世界の凝固因子濃縮物市場 2019年
DATA909X05576 / QYResearch / 2019年11月15日 / ※本調査レポートは、凝固因子濃縮物の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、凝固因子IX、凝固因子XIII、その他に、用途別には、病院と診療所、研究所、学術機関にセグメント区分し、凝固因子濃縮物の世界市場を分析しました。・エグゼクティブ・サマリー・凝固因子濃縮物の世界市場概要・凝固因子濃縮物の製造コスト構成分析・凝固因子濃縮物の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・凝固因子濃縮物の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・凝固因子濃縮物のセグメント分析（種類別）（凝固因子IX、凝固因子XIII、その他）...The global Coagulation Factor Concentrate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coagulation Factor Concentrate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coagulation Factor Concentrate market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coagulation Factor Concentrate in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

世界のプラスミノーゲン活性化剤阻害剤市場 2019年
DATA909X13125 / QYResearch / 2019年11月20日 / ※本調査レポートは、プラスミノーゲン活性化剤阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、PAI-1、TIMP-1に、用途別には、医療、その他にセグメント区分し、プラスミノーゲン活性化剤阻害剤の世界市場を分析しました。・エグゼクティブ・サマリー・プラスミノーゲン活性化剤阻害剤の世界市場概要・プラスミノーゲン活性化剤阻害剤の製造コスト構成分析・プラスミノーゲン活性化剤阻害剤の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・プラスミノーゲン活性化剤阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・プラスミノーゲン活性化剤阻害剤のセグメント分析（種類別）（PAI-1、TIMP-1）...The global Plasminogen Activator Inhibitor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Plasminogen Activator Inhibitor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Plasminogen Activator Inhibitor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Plasminogen Activator Inhibitor in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

世界のレチノイン酸受容体アルファ市場 2019年
DATA909X14351 / QYResearch / 2019年11月20日 / ※本調査レポートは、レチノイン酸受容体アルファの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アリトレチノイン、IRX-5183、SBD-073、タミバロテン、その他に、用途別には、骨髄異形成症候群、急性骨髄性白血病、ホルモン感受性乳がん、その他にセグメント区分し、レチノイン酸受容体アルファの世界市場を分析しました。・エグゼクティブ・サマリー・レチノイン酸受容体アルファの世界市場概要・レチノイン酸受容体アルファの製造コスト構成分析・レチノイン酸受容体アルファの開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・レチノイン酸受容体アルファの地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・レチノイン酸受容体アルファのセグメント分析（種類別）（アリトレチノイン、IRX-5183、SBD-073、タミバロテン、その他）...The global Retinoic Acid Receptor Alpha market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Retinoic Acid Receptor Alpha volume and value at global level, regional level and company level. From a global perspective, this report represents overall Retinoic Acid Receptor Alpha market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Retinoic Acid Receptor Alpha in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

◆H&Iグローバルリサーチのお客様（例）◆

世界の市場調査レポート

世界の低酸素誘導因子1アルファ阻害剤市場 2019年

市場調査レポート・産業資料総合販売サイト MarketReport.jp

市場調査レポート・産業資料 総合販売サイト MarketReport.jp

市場調査レポート・産業資料総合販売サイト MarketReport.jp